EC Clinical and Medical Case Reports

Behcet’s disease is a vasculitis of unknown etiology that affects blood vessels of all sizes, and in which venous lesions are remarkably frequent. Patients with this condition experience recurrent symptoms, whose severity and frequency decrease over time. However, complications may be severe. Although the mortality rate - mainly due to major vessel disease - is relatively low, Behcet’s disease is associated with high morbidity rates. Diagnosis is based on certain characteristic symptoms, primarily oral or genital-oral ulcerations, as well as other systemic manifestations. Pancreatitis is yet another but rare manifestation, scarcely mentioned in literature. We report the case of a patient with Behcet’s disease who presented an acute pancreatitis.

Keywords: Acute Pancreatitis; Behcet; Organ Dysfunction

1. La Lee. “Behcet's disease”. Seminars in Cutaneous Medicine and Surgery1 (2001): 53-57.
2. N Dilsen. “History and evolution of Behcet's disease University of Istanbul, Istanbul Medical School, Turkey”. Revue du Rhumatisme English Edition7-8 (1996): 512-519.
3. Daniel Elbirt., et al. “Behcet's disease - clinical presentation, diagnostic and therapeutic approach”. Medical Center, Rehovot Harefuah 141.5 (2002): 462-467.
4. Adriana A Bonfioli and Fernando Orefice. “Behcet's disease”. Seminars in Ophthalmology3 (2005): 199-206.
5. Mason RM and Bares CG. “Behcet's syndrome with arthritis”. Annals of Rheumatic Diseases2 (1969): 95-103.
6. Japanese Behcet's Disease Research Committee. “Behcet's Disease Guide for Diagnosis of Behcet's Disease Behçet”. Japanese Journal of Ophthalmology 18 (1974): 291-294.
7. Proposed criteria for the diagnosis of Behcet's disease and therapeutic notes”. Journal of Medicine Revue de Médecine 36 (1974): 2371-2379.
8. Hamza M. “Behcet's disease”. In: Kahn MF, Peltier AP, Meyer 0, Piette JC edition. Diseases and syndromes. Flammarion Medicine, Paris (2000): 883-924.
9. International Behcet's Disease Study Group. “Diagnostic Criteria for Behcet's Disease”. Lancet8697 (1990): 1078-1080.
10. Davatchi F., et al. “Evaluation and revision of the International Study Group Criteria for Behçet's disease”. ACR (2007): 465.
11. Davatchi F., et al. “Adult Behcet's disease in Iran: analysis of 6075 patients”. International Journal of Rheumatic Diseases1 (2016): 95-103.
12. Hassikou H and Hassikou H. “Kidney damage during Behçet's disease”. Revue du Rhumatisme10-11 (2006): 1218.
13. Lemrini M., et al. “Renal amyloidosis, a rare complication of the disease of Behçet”. Therapeutic Nephrology5 (2011): 435-436.
14. Zeidan MJ., et al. “Behçet's disease physiopathology: a contemporary review”. Autoimmunity Highlights1 (2016).
15. Lopalco G., et al. “Update on the Medical Management of Gastrointestinal Behçet's Disease”. Mediators of Inflammation (2017): 1-11.
16. Y Bayraktar., et al. “Thiel Gastrointestinal manifestations of Behcet's disease”. Journal of Clinical Gastroenterology2 (2000): 144-154.
17. Lakhanpal S., et al. “Pathological features of Behcet's syndrome: a review of Japanese autopsy registry data”. Human Pathology 16 (1985): 790-795.
18. Grigg EL., et al. “Mimicry and deception in inflammatory Bowel disease and intestinal Behcet disease”. Gastroenterology and Hepatology2 (2012): 103-112.
19. O'Duffy JD., et al. “Behcet's disease. Report of 10 cases, 3 with new manifestations”. Annals of Internal Medicine3 (1971): 561-570.
20. Le Thi Huong D., et al. “Acute Pancreatitis in Behcet's disease”. Digestive Diseases and Sciences9 (1992): 1452-1453.
21. Backmund M and Schomerus P. “Acute pancreatitis and pericardial effusion in Behcet's disease”. Gastroenterology1 (1999): 286.
22. Ben Yaghlene L., et al. “Acute pancreatitis revealing Behçet disease”. Gastroentérologie Clinique et Biologique3 (2005): 294-296.
23. Alkim H., et al. “Chronic pancreatitis and aortic pseudoaneurysm in Behcet's disease”. The American Journal of Gastroenterology2 (2001): 591-593.
24. Zhang L and Smyrk TC. “Autoimmune pancreatitis and IgG4-related systemic diseases”. International Journal of Clinical and Experimental Pathology5 (2010): 491-504.
25. Floyd A., et al. “Risk of acute pancreatitis in users of azathioprine: a population-based case-control study”. The American Journal of Gastroenterology6 (2003): 1305-1308.
26. Lopez-Martin C., et al. “Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease”. Journal of Gastroenterology and Hepatology6 (2011): 385-392.